Aim Therapeutics Inc.
Records under this name other than patents Aim Therapeutics Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 5 of 5 · Back to Aim Therapeutics Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,153,835 | Anti-inflammatory peptides Lapsed on the fee record Ended Dec 26, 2018 · From the USPTO record | Lapsed on the fee record | Ended Dec 26, 2018 | From the USPTO record |
| US 7,833,986 | Anti-inflammatory peptides Lapsed on the fee record Ended Nov 16, 2018 · From the USPTO record | Lapsed on the fee record | Ended Nov 16, 2018 | From the USPTO record |
| US 6,852,697 | Peptides for treatment of inflammation and shock Lapsed on the fee record Ended Feb 8, 2017 · From the USPTO record | Lapsed on the fee record | Ended Feb 8, 2017 | From the USPTO record |
| US 7,094,760 | Peptides for treatment of inflammation and shock Lapsed on the fee record Ended Aug 22, 2014 · From the USPTO record | Lapsed on the fee record | Ended Aug 22, 2014 | From the USPTO record |
| US 6,586,403 | Treating allergic reactions and inflammatory responses with tri-and dipeptides Lapsed on the fee record Ended Jul 1, 2011 · From the USPTO record | Lapsed on the fee record | Ended Jul 1, 2011 | From the USPTO record |